Sweeney, N. J. et al. The Escherichia coli K-12 gntP gene allows E. coli F-18 to occupy a distinct nutritional niche in the streptomycin-treated mouse large intestine. Infect. Immun. 64, 34973503 (1996).
Nataro, J. P. & Kaper, J. B. Diarrheagenic Escherichia coli. Clin. Microbiol. Rev. 11, 142201 (1998). A comprehensive review of the pathogenesis, epidemiology, diagnosis and clinical aspects of diarrhoeagenic E. coli.
Russo, T. A. & Johnson, J. R. Proposal for a new inclusive designation for extraintestinal pathogenic isolates of Escherichia coli: ExPEC. J. Infect. Dis. 181, 17531754 (2000).
Whittam, T. S. in Escherichia coli and Salmonella (eds Neidhardt, F. C. et al.) 27082720 (ASM Press, Washington DC, USA, 1996).
Cassels, F. J. & Wolf, M. K. Colonization factors of diarrheagenic E. coli and their intestinal receptors. J. Ind. Microbiol. 15, 214226 (1995).
Keller, R. et al. Afa, a diffuse adherence fibrillar adhesin associated with enteropathogenic Escherichia coli. Infect. Immun. 70, 26812689 (2002).
Tieng, V. et al. Binding of Escherichia coli adhesin AfaE to CD55 triggers cell-surface expression of the MHC class I-related molecule MICA. Proc. Natl Acad. Sci. USA 99, 29772982 (2002).
Goldberg, M. B. & Theriot, J. A. Shigella flexneri surface protein IcsA is sufficient to direct actin-based motility. Proc. Natl Acad. Sci. USA 92, 65726576 (1995).
Tapping, R. I., Akashi, S., Miyake, K., Godowski, P. J. & Tobias, P. S. Toll-like receptor 4, but not toll-like receptor 2, is a signaling receptor for Escherichia and Salmonella lipopolysaccharides. J. Immunol. 165, 57805787 (2000).
Hayashi, F. et al. The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5. Nature 410, 10991103 (2001).
Sears, C. L. & Kaper, J. B. Enteric bacterial toxins: mechanisms of action and linkage to intestinal secretion. Microbiol. Rev. 60, 167215 (1996).
Melton-Celsa, A. R. & O'Brien, A. D. in Escherichia coli O157:H7 and Other Shiga Toxin-Producing E. coli Strains (eds Kaper, J. B. & O'Brien, A. D.) 121128 (ASM Press, Washington DC, USA, 1998).
De Rycke, J. & Oswald, E. Cytolethal distending toxin (CDT): a bacterial weapon to control host cell proliferation? FEMS Microbiol Lett. 203, 141148 (2001).
Marches, O. et al. Enteropathogenic and enterohaemorrhagic Eschericha coli deliver a novel effector called Cif, which blocks cell cycle G2/M transition. Mol. Microbiol 50, 15531567 (2003).
Lerm, M. et al. Deamidation of Cdc42 and Rac by Escherichia coli cytotoxic necrotizing factor 1: activation of c-Jun N-terminal kinase in HeLa cells. Infect. Immun. 67, 496503 (1999).
Kenny, B. et al. Co-ordinate regulation of distinct host cell signalling pathways by multifunctional enteropathogenic Escherichia coli effector molecules. Mol. Microbiol. 44, 10951107 (2002).
Tauschek, M., Gorrell, R. J., Strugnell, R. A. & Robins-Browne, R. M. Identification of a protein secretory pathway for the secretion of heat-labile enterotoxin by an enterotoxigenic strain of Escherichia coli. Proc. Natl Acad. Sci. USA 99, 70667071 (2002).
Henderson, I. R., Navarro-Garcia, F. & Nataro, J. P. The great escape: structure and function of the autotransporter proteins. Trends Microbiol. 6, 370378 (1998).
Hueck, C. J. Type III protein secretion systems in bacterial pathogens of animals and plants. Microbiol. Mol. Biol. Rev. 62, 379433 (1998).
Balakrishnan, L., Hughes, C. & Koronakis, V. Substrate-triggered recruitment of the TolC channel-tunnel during type I export of hemolysin by Escherichia coli. J. Mol. Biol. 313, 501510 (2001).
McDaniel, T. K., Jarvis, K. G., Donnenberg, M. S. & Kaper, J. B. A genetic locus of enterocyte effacement conserved among diverse enterobacterial pathogens. Proc. Natl Acad. Sci. USA 92, 16641668 (1995). The first description of a pathogenicity island in enteric E. coli pathotypes.
Jerse, A. E., Yu, J., Tall, B. D. & Kaper, J. B. A genetic locus of enteropathogenic Escherichia coli necessary for the production of attaching and effacing lesions on tissue culture cells. Proc. Natl Acad. Sci. USA 87, 78397843 (1990).
Higgins, L. M. et al. Role of bacterial intimin in colonic hyperplasia and inflammation. Science 285, 588591 (1999).
Kenny, B. et al. Enteropathogenic E. coli (EPEC) transfers its receptor for intimate adherence into mammalian cells. Cell 91, 511520 (1997). The first report of a bacterium translocating its receptor into mammalian cells by a type III secretion system.
Muza-Moons, M. M., Koutsouris, A. & Hecht, G. Disruption of cell polarity by enteropathogenic Escherichia coli enables basolateral membrane proteins to migrate apically and to potentiate physiological consequences. Infect. Immun. 71, 70697078 (2003).
Sinclair, J. F. & O'Brien, A. D. Cell surface-localized nucleolin is a eukaryotic receptor for the adhesin intimin- of enterohemorrhagic Escherichia coli O157:H7. J. Biol. Chem. 277, 28762885 (2002).
Kalman, D. et al. Enteropathogenic E. coli acts through WASP and Arp2/3 complex to form actin pedestals. Nature Cell Biol. 1, 389391 (1999).
Campellone, K. G. & Leong, J. M. Tails of two Tirs: actin pedestal formation by enteropathogenic E. coli and enterohemorrhagic E. coli O157:H7. Curr. Opin. Microbiol. 6, 8290 (2003).
Vallance, B. A. & Finlay, B. B. Exploitation of host cells by enteropathogenic Escherichia coli. Proc. Natl Acad. Sci. USA 97, 87998806 (2000).
Sanger, J. M., Chang, R., Ashton, F., Kaper, J. B. & Sanger, J. W. Novel form of actin-based motility transports bacteria on the surface of infected cells. Cell Motil. Cytoskeleton 34, 279287 (1996).
Crane, J. K., McNamara, B. P. & Donnenberg, M. S. Role of EspF in host cell death induced by enteropathogenic Escherichia coli. Cell Microbiol. 3, 197211 (2001).
McNamara, B. P. et al. Translocated EspF protein from enteropathogenic Escherichia coli disrupts host intestinal barrier function. J. Clin. Invest. 107, 621629 (2001).
Klapproth, J. M. et al. A large toxin from pathogenic Escherichia coli strains that inhibits lymphocyte activation. Infect. Immun. 68, 21482155 (2000).
Nicholls, L., Grant, T. H. & Robins-Browne, R. M. Identification of a novel genetic locus that is required for in vitro adhesion of a clinical isolate of enterohaemorrhagic Escherichia coli to epithelial cells. Mol. Microbiol. 35, 275288 (2000).
Tobe, T. et al. Complete DNA sequence and structural analysis of the enteropathogenic Escherichia coli adherence factor plasmid. Infect. Immun. 67, 54555462 (1999).
Girn, J. A., Ho, A. S. Y. & Schoolnik, G. K. An inducible bundle-forming pilus of enteropathogenic Escherichia coli. Science 254, 710713 (1991).
Trabulsi, L. R., Keller, R. & Tardelli Gomes, T. A. Typical and atypical enteropathogenic Escherichia coli. Emerg. Infect. Dis. 8, 508513 (2002).
Hecht, G. Microbes and microbial toxins: paradigms for microbialmucosal interactions. VII. Enteropathogenic Escherichia coli: physiological alterations from an extracellular position. Am. J. Physiol Gastrointest. Liver Physiol. 281, G1G7 (2001).
Frankel, G. et al. Enteropathogenic and enterohaemorrhagic Escherichia coli: more subversive elements. Mol. Microbiol. 30, 911921 (1998).
Kenny, B. Mechanism of action of EPEC type III effector molecules. Int. J. Med. Microbiol. 291, 469477 (2002).
Hecht, G. et al. Pathogenic Escherichia coli increase Cl secretion from intestinal epithelia by upregulating galanin-1 receptor expression. J. Clin. Invest. 104, 253262 (1999).
Varma, J. K. et al. An outbreak of Escherichia coli O157 infection following exposure to a contaminated building. JAMA 290, 27092712 (2003).
Andreoli, S. P., Trachtman, H., Acheson, D. W., Siegler, R. L. & Obrig, T. G. Hemolytic uremic syndrome: epidemiology, pathophysiology, and therapy. Pediatr. Nephrol. 17, 293298 (2002).
Jones, N. L. et al. Escherichia coli Shiga toxins induce apoptosis in epithelial cells that is regulated by the Bcl-2 family. Am. J. Physiol. Gastrointest. Liver Physiol. 278, G811G819 (2000).
Reid, S. D., Herbelin, C. J., Bumbaugh, A. C., Selander, R. K. & Whittam, T. S. Parallel evolution of virulence in pathogenic Escherichia coli. Nature 406, 6467 (2000).
Tatsuno, I. et al. toxB gene on pO157 of enterohemorrhagic Escherichia coli O157:H7 is required for full epithelial cell adherence phenotype. Infect. Immun. 69, 66606669 (2001).
Burland, V. et al. The complete DNA sequence and analysis of the large virulence plasmid of Escherichia coli O157:H7. Nucleic Acids Res. 26, 41964204 (1998).
Lathem, W. W. et al. StcE, a metalloprotease secreted by Escherichia coli O157:H7, specifically cleaves C1 esterase inhibitor. Mol. Microbiol. 45, 277288 (2002).
Perna, N. T. et al. Genome sequence of enterohaemorrhagic Escherichia coli O157:H7. Nature 409, 529533 (2001). The first reported genome sequence for a pathogenic E. coli strain.
Heimer, S. R. et al. Urease of enterohemorrhagic Escherichia coli: evidence for regulation by fur and a trans-acting factor. Infect. Immun. 70, 10271031 (2002).
Wolf, M. K. Occurrence, distribution, and associations of O and H serogroups, colonization factor antigens, and toxins of enterotoxigenic Escherichia coli. Clin. Microbiol. Rev. 10, 569584 (1997).
Spangler, B. D. Structure and function of cholera toxin and the related Escherichia coli heat-labile enterotoxin. Microbiol. Rev. 56, 622647 (1992).
Pizza, M. et al. Mucosal vaccines: non-toxic derivatives of LT and CT as mucosal adjuvants. Vaccine 19, 25342541 (2001).
Currie, M. G. et al. Guanylin: an endogenous activator of intestinal guanylate cyclase. Proc. Natl Acad. Sci. USA 89, 947951 (1992). This paper suggests that STa evolved as a molecular mimic of an endogenous ligand. This model is necessary, not only to understand ETEC pathogenesis and evolution, but also to provide a context for future studies of microbial evolution.
Dubreuil, J. D. Escherichia coli STb enterotoxin. Microbiology 143, 17831795 (1997).
Pitari, G. M. et al. Bacterial enterotoxins are associated with resistance to colon cancer. Proc. Natl Acad. Sci. USA 100, 26952699 (2003).
Nataro, J. P., Steiner, T. S. & Guerrant, R. L. Enteroaggregative Escherichia coli. Emerg. Infect. Dis. 4, 251261 (1998).
Hicks, S., Candy, D. C. A. & Phillips, A. D. Adhesion of enteroaggregative Escherichia coli to pediatric intestinal mucosa in vitro. Infect. Immun. 64, 47514760 (1996).
Vial, P. A. et al. Characterization of enteroadherent-aggregative Escherichia coli, a putative agent of diarrheal disease. J. Infect. Dis. 158, 7079 (1988).
Benjamin, P., Federman, M. & Wanke, C. A. Characterization of an invasive phenotype associated with enteroaggregative Escherichia coli. Infect. Immun. 63, 34173421 (1995).
Abe, C. M., Knutton, S., Pedroso, M. Z., Freymuller, E. & Gomes, T. A. An enteroaggregative Escherichia coli strain of serotype O111:H12 damages and invades cultured T84 cells and human colonic mucosa. FEMS Microbiol. Lett. 203, 199205 (2001).
Czeczulin, J. R. et al. Aggregative adherence fimbria II, a second fimbrial antigen mediating aggregative adherence in enteroaggregative Escherichia coli. Infect. Immun. 65, 41354145 (1997).
Nataro, J. P. et al. Aggregative adherence fimbriae I of enteroaggregative Escherichia coli mediate adherence to HEp-2 cells and hemagglutination of human erythrocytes. Infect. Immun. 60, 22972304 (1992).
Nataro, J. P., Yikang, D., Yingkang, D. & Walker, K. AggR, a transcriptional activator of aggregative adherence fimbria I expression in enteroaggregative Escherichia coli. J. Bacteriol. 176, 46914699 (1994). Describes the emergence of AggR as a global regulator of virulence genes in EAEC
Sheikh, J. et al. A novel dispersin protein in enteroaggregative Escherichia coli. J. Clin. Invest. 110, 13291337 (2002).
Steiner, T. S., Nataro, J. P., Poteet-Smith, C. E., Smith, J. A. & Guerrant, R. L. Enteroaggregative Escherichia coli expresses a novel flagellin that causes IL-8 release from intestinal epithelial cells. J. Clin. Invest 105, 17691777 (2000). The pathogenesis of EAEC is not completely understood, but inflammation might be an important component.
Henderson, I. R., Czeczulin, J., Eslava, C., Noriega, F. & Nataro, J. P. Characterization of Pic, a secreted protease of Shigella flexneri and enteroaggregative Escherichia coli. Infect. Immun. 67, 55875596 (1999).
Noriega, F. R., Liao, F. M., Formal, S. B., Fasano, A. & Levine, M. M. Prevalence of Shigella enterotoxin 1 among Shigella clinical isolates of diverse serotypes. J. Infect. Dis. 172, 14081410 (1995).
Savarino, S. J. et al. Enteroaggregative Escherichia coli heat-stable enterotoxin 1 represents another subfamily of E. coli heat-stable toxin. Proc. Natl Acad. Sci. USA 90, 30933097 (1993).
Menard, L. P. & Dubreuil, J. D. Enteroaggregative Escherichia coli heat-stable enterotoxin 1 (EAST1): a new toxin with an old twist. Crit. Rev. Microbiol. 28, 4360 (2002).
Navarro-Garcia, F. et al. In vitro effects of a high-molecular weight heat-labile enterotoxin from enteroaggregative Escherichia coli. Infect. Immun. 66, 31493154 (1998).
Jiang, Z. D., Greenberg, D., Nataro, J. P., Steffen, R. & DuPont, H. L. Rate of occurrence and pathogenic effect of enteroaggregative Escherichia coli virulence factors in international travelers. J. Clin. Microbiol. 40, 41854190 (2002).
Wei, J. et al. Complete genome sequence and comparative genomics of Shigella flexneri serotype 2a strain 2457T. Infect. Immun. 71, 27752786 (2003).
Pupo, G. M., Lan, R. & Reeves, P. R. Multiple independent origins of Shigella clones of Escherichia coli and convergent evolution of many of their characteristics. Proc. Natl Acad. Sci. USA 97, 1056710572 (2000). This paper suggests that Shigella should be considered within the species Escherichia coli , and that their evolution represents adaptation to a specific pathogenetic niche, a phenomenon that has occurred on several occasions over many years.
Sansonetti, P. Hostpathogen interactions: the seduction of molecular cross talk. Gut 50, Suppl. 3 S2S8 (2002).
Zychlinsky, A., Prevost, M. C. & Sansonetti, P. J. Shigella flexneri induces apoptosis in infected macrophages. Nature 358, 167169 (1992).
Buchrieser, C. et al. The virulence plasmid pWR100 and the repertoire of proteins secreted by the type III secretion apparatus of Shigella flexneri. Mol. Microbiol. 38, 760771 (2000).
Egile, C. et al. Activation of the CDC42 effector N-WASP by the Shigella flexneri IcsA protein promotes actin nucleation by Arp2/3 complex and bacterial actin- based motility. J. Cell Biol. 146, 13191332 (1999).
Sansonetti, P. J. et al. Caspase-1 activation of IL-1 and IL-18 are essential for Shigella flexneri-induced inflammation. Immunity. 12, 581590 (2000). The pathogenesis of Shigella infection represents a complex manipulation of the immune response, in ways that are beneficial to both pathogen and host.
Tran Van Nhieu, G., Bourdet-Sicard, R., Dumenil, G., Blocker, A. & Sansonetti, P. J. Bacterial signals and cell responses during Shigella entry into epithelial cells. Cell. Microbiol. 2, 187193 (2000).
Niebuhr, K. et al. Conversion of PtdIns(4,5)P2 into PtdIns5P by the S. flexneri effector IpgD reorganizes host cell morphology. EMBO J. 21, 50695078 (2002).
Scaletsky, I. C. et al. Diffusely adherent Escherichia coli as a cause of acute diarrhea in young children in northeast Brazil: a case-control study. J. Clin. Microbiol. 40, 645648 (2002).
Bilge, S. S., Clausen, C. R., Lau, W. & Moseley, S. L. Molecular characterization of a fimbrial adhesin, F1845, mediating diffuse adherence of diarrhea-associated Escherichia coli to HEp-2 cells. J. Bacteriol. 171, 42814289 (1989).
Hasan, R. J. et al. Structurefunction analysis of decayaccelerating factor: identification of residues important for binding of the Escherichia coli Dr adhesin and complement regulation. Infect. Immun. 70, 44854493 (2002).
Bernet-Camard, M. F., Coconnier, M. H., Hudault, S. & Servin, A. L. Pathogenicity of the diffusely adhering strain Escherichia coli C1845: F1845 adhesin-decay accelerating factor interaction, brush border microvillus injury, and actin disassembly in cultured human intestinal epithelial cells. Infect. Immun. 64, 19181928 (1996).
Peiffer, I., Servin, A. L. & Bernet-Camard, M. F. Piracy of decay-accelerating factor (CD55) signal transduction by the diffusely adhering strain Escherichia coli C1845 promotes cytoskeletal F-actin rearrangements in cultured human intestinal INT407 cells. Infect. Immun. 66, 40364042 (1998). DAEC exhibits a unique pathogenetic scheme that includes cytoskeletal sabotage.
Peiffer, I., Bernet-Camard, M. F., Rousset, M. & Servin, A. L. Impairments in enzyme activity and biosynthesis of brush border-associated hydrolases in human intestinal Caco-2/TC7 cells infected by members of the Afa/Dr family of diffusely adhering Escherichia coli. Cell. Microbiol. 3, 341357 (2001).
Phillips, I. et al. Epidemic multiresistant Escherichia coli infection in West Lambeth Health District. Lancet 1, 10381041 (1988).
Manges, A. R. et al. Widespread distribution of urinary tract infections caused by a multidrug-resistant Escherichia coli clonal group. N. Engl. J. Med. 345, 10071013 (2001). This work identified specific clonal groups of E. coli that cause widespread antibiotic resistant bacteria.
Nowicki, B., Svanborg-Eden, C., Hull, R. & Hull, S. Molecular analysis and epidemiology of the Dr hemagglutinin of uropathogenic Escherichia coli. Infect. Immun. 57, 446451 (1989).
Johnson, J. R. Virulence factors in Escherichia coli urinary tract infection. Clin. Microbiol. Rev. 4, 80128 (1991).
Johnson, J. R. & Stell, A. L. Extended virulence genotypes of Escherichia coli strains from patients with urosepsis in relation to phylogeny and host compromise. J. Infect. Dis. 181, 261272 (2000).
Welch, R. A. et al. Extensive mosaic structure revealed by the complete genome sequence of uropathogenic Escherichia coli. Proc. Natl Acad. Sci. USA 99, 1702017024 (2002). The first complete nucleotide sequence of a representative uropathogenic strain of E. coli and shows that EHEC, UPEC and E. coli K-12 share only 39.2% of the combined set of predicted proteins.
Bahrani-Mougeot, F. K. et al. Type 1 fimbriae and extracellular polysaccharides are preeminent uropathogenic Escherichia coli virulence determinants in the murine urinary tract. Mol. Microbiol. 45, 10791093 (2002).
Gunther, N. W., Lockatell, V., Johnson, D. E. & Mobley, H. L. In vivo dynamics of type 1 fimbria regulation in uropathogenic Escherichia coli during experimental urinary tract infection. Infect. Immun. 69, 28382846 (2001).
Connell, I. et al. Type 1 fimbrial expression enhances Escherichia coli virulence for the urinary tract. Proc. Natl Acad. Sci. USA 93, 98279832 (1996). Demonstrates that type 1 fimbriae satisfies molecular Koch's postulates.
Mulvey, M. A. et al. Induction and evasion of host defenses by type 1-piliated uropathogenic Escherichia coli. Science 282, 14941497 (1998).
Anderson, G. G. et al. Intracellular bacterial biofilm-like pods in urinary tract infections. Science 301, 105107 (2003).
Svanborg-Eden, C. & Hansson, H. A. Escherichia coli pili as possible mediators of attachment to human urinary tract epithelial cells. Infect. Immun. 21, 229237 (1978).
Korhonen, T. K., Virkola, R. & Holthofer, H. Localization of binding sites for purified Escherichia coli P fimbriae in the human kidney. Infect. Immun. 54, 328332 (1986).
Continue reading here:
Pathogenic Escherichia coli | Nature Reviews Microbiology
- Weekly pick of brain tumour research news from around the world - Brain Tumour Research - January 25th, 2020
- First pain treatment using human stem cells developed - THE WEEK - January 25th, 2020
- Researchers uncover link between the nervous system - Tdnews - January 25th, 2020
- Snake Venom Gland Organoids Produce Functional Toxins - The Scientist - January 24th, 2020
- Trump and the March for Life - The Bulwark - January 24th, 2020
- How I Went From Managing Complexity to Becoming a U.S. Ambassador and CEO - SWAAY - January 24th, 2020
- Stem Cell Cartilage Regeneration Market to Witness Robust Expansion Throughout the Forecast Period 2020-2026 - Vital News 24 - January 24th, 2020
- Stem Cell Assay Market Booming by Size, Revenue, Trend and Top Growing Companies 2026 - Vital News 24 - January 24th, 2020
- Stem Cell Banking Market smart Strategies of the Research and Development Process Dagoretti News - Dagoretti News - January 23rd, 2020
- Meet the Culprits of Cell Culture Contamination - Technology Networks - January 23rd, 2020
- What Will Be The Growth of Animal Stem Cell Therapy Market? Dagoretti News - Dagoretti News - January 23rd, 2020
- Biobanks Market To Witness An Impressive Growth During The Forecast Period 2017 2025 Dagoretti News - Dagoretti News - January 23rd, 2020
- Stem Cell Alopecia Treatment Market Booming by Size, Revenue, Trend and Top Growing Companies 2026 - Vital News 24 - January 23rd, 2020
- Advancells Group & IFC Concluded their 3-Day Workshop on Regenerative Medicine - India Education Diary - January 23rd, 2020
- Stem Cell Therapy Market : Segmentation, Industry Trends and Development to 2019-2026 - Fusion Science Academy - January 23rd, 2020
- BrainStorm Cell Therapeutics COO and CMO, Dr. Ralph Kern, to Present at the 10th Annual California ALS Research Summit - Yahoo Finance - January 22nd, 2020
- Neurogenesis could be a therapeutic target in neurodegenerative disease - Drug Target Review - January 22nd, 2020
- Getting to the Root of the Disease: Developing Drugs Against the Hard-to-Target Wnt Pathway - BioSpace - January 22nd, 2020
- Animal Stem Cell Therapy Market Global and Regional Analysis by Top Key Market Players, Key Regions, Product Segments, and Applications 2024 ... - January 22nd, 2020
- At 35.7% CAGR, Animal Stem Cell Therapy Market Size will reach 108.3 million USD by 2025 - MENAFN.COM - January 22nd, 2020
- Global Cholangiocarcinoma Therapeutics Market 2019-2023 | Evolving Opportunities with Bristol-Myers Squibb Company and Eli Lilly and Company |... - January 22nd, 2020
- 1000 Entrepreneurs: Ken Aldrich on 30 Years of Venture Capital and 50 Successful Businesses - GuruFocus.com - January 22nd, 2020
- Preparing the youth - The News International - January 22nd, 2020
- Canine Stem Cell Therapy Market Extensive Growth Opportunities to Be Witnessed by 2019-2026 - Fusion Science Academy - January 22nd, 2020
- Cell Separation Technologies Market Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2019 2026 - Dagoretti News - January 22nd, 2020
- Europe's guardian of stem cells and hopes, real and unrealistic - FRANCE 24 - January 21st, 2020
- Psychiatric body condemns use of stem cell therapies to treat psychiatric disorders - Moneycontrol.com - January 21st, 2020
- Astellas partners with Adaptimmune to develop off-the-shelf CAR-T and T-cell therapies - Healio - January 21st, 2020
- Could Scientists 'Hack' the Zika Virus to Kill Brain Cancer? - Livescience.com - January 20th, 2020
- Product Innovations and Technological Advancements to Boost the Growth of the Stem Cell Therapy Market in the Upcoming Years 2017 2025 Dagoretti... - January 20th, 2020
- Stem Cell Cartilage Regeneration Market Report 2019:2026 Industry Growth Forecasts by Manufacturers, Countries, Type and Application Dagoretti News... - January 20th, 2020
- Market opportunity and growth drivers of Cell Separation Technology Market till 2025 Dagoretti News - Dagoretti News - January 20th, 2020
- Stem Cell Research: Uses, Types & Examples - January 19th, 2020
- Stem Cell Assay Market expected to Witness a Sustainable Growth over 2016 2024 Dagoretti News - Dagoretti News - January 19th, 2020
- 2D Cell Culture Market to Witness Growth Acceleration During 2020 to 2026 Dagoretti News - Dagoretti News - January 19th, 2020
- Stem Cell and Progenitor Cell-based therapeutics Market 2020 Share Growing Rapidly with Recent Trends, Growth, Size, Share, Clinical Review,... - January 18th, 2020
- Animal Stem Cell Therapy Market Poised to Garner Maximum Revenues During 2017 2025 Dagoretti News - Dagoretti News - January 18th, 2020
- Astellas and Adaptimmune Enter into Agreement to Co-Develop and Co-Commercialize Stem-Cell Derived Allogeneic CAR-T and TCR T-Cell Therapies - Yahoo... - January 18th, 2020
- Universities aren't making a lot of money from university research - The Hechinger Report - January 18th, 2020
- R&D Activities to Fast-track the Growth of the Biobanks Market Between 2017 2025 Dagoretti News - Dagoretti News - January 18th, 2020
- Rheumatoid Arthritis Stem Cell Therapy Market Latest Innovations, Drivers and Industry Key Events 2018 to 2028 - Fusion Science Academy - January 18th, 2020
- Heart Cell Research Leads to Discovery That May Lead to Unreliable Data - Newswise - January 17th, 2020
- Global Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market 2019 Valuable Growth Prospects and Upcoming Trends till 2024 Dagoretti News... - January 17th, 2020
- In Vitro Lung Model Market to 2027 Increasing Adoption Of 3D Model Systems - PharmiWeb.com - January 17th, 2020
- Curcumin Combined with Thalidomide Reduces Expression of STAT3 and Bcl | DDDT - Dove Medical Press - January 15th, 2020
- Global Stem Cell Reconstructive Market 2019 Share, Trend, Segmentation and Forecast to 2025 - Instanews247 - January 15th, 2020
- The Checkout: Powering Plant and Cell-based Innovations - NOSH - January 11th, 2020
- Cultured Meat Startup New Age Meats Secures $2.7M in Seed Round - vegconomist - the vegan business magazine - January 11th, 2020
- Stem Cell Gun Devices Market Projected to Witness Vigorous Expansion by 2019 2027 - Food & Beverage Herald - January 11th, 2020
- Stem Cell Manufacturing Market Size, Top Companies, Business Opportunities and Growth 2020 to 2027 - Pro News Time - January 11th, 2020
- TEDCO funds open again for applications - Maryland Daily Record - January 4th, 2020
- Cell Culture Protein Surface Coating Market Competitive Environment and Higher Growth Rate with Forecast to 2025 - Filmi Baba - January 4th, 2020
- Stem Cell Alopecia Treatment Market Segmentation, Top Companies, Applications, Comprehensive Research Report and Forecast to 2026 - Market Research... - December 30th, 2019
- Animal Stem Cell Therapy Market Research Report 2026 Observational Studies With Top Manufacturers - Market Research Sheets - December 30th, 2019
- Stem Cell Cartilage Regeneration Market Key players, Geographical Regions and Growth Analysis Outlook Up To 2028 - Sound On Sound Fest - December 30th, 2019
- Scientists race to use zero gravity to kill the worst cancers - Big Think - December 30th, 2019
- How technology has changed the world in the last decade - The Upcoming - December 30th, 2019
- Stem Cell Market Analysis, Growth By Top Companies, Trends By Types And Application, Forecast Analysis To 2027 - Market Research Sheets - December 30th, 2019
- Don't throw food in the trash in Vermont, or ask about salary history in New Jersey. Here are 7 state law changes for 2020 - USA TODAY - December 28th, 2019
- From the image of a black hole to 'artificial embryos', 2019 was the year of many firsts in science - Economic Times - December 28th, 2019
- Animal Stem Cell Therapy Market: Challenges and Opportunities Report 2017 2025 Bulletin Line - Bulletin Line - December 28th, 2019
- Protein Associated with Leukemia May Lead to Targeted Therapy for Currently Incurable Acute Lymphoblastic Leukemia - Pharmacy Times - December 25th, 2019
- The Next Generation of Biologic Pacemakers? New Discovery in Stem Cells from Fat Creates Another Alternative Treatment - DocWire News - December 25th, 2019
- Study of the 3D Cell Culture Market in Asia-Pacific, 2019-2027: Projecting a 13.11% CAGR, Driven by Promising Developments Using Regenerative Medicine... - December 24th, 2019
- Stem Cells Market Poised to Expand at a Robust Pace Over 2017 to 2025 - Market Research Sheets - December 24th, 2019
- Illuminating Christmas, 19 years and counting... in honour of the Anthony Nolan Charity - London News Online - December 24th, 2019
- The global in vitro lung model market is expected to reach US$ 701.81 Mn in 2027 from US$ 185.80 Mn in 2018 - Yahoo Finance - December 24th, 2019
- Global and Southeast Asia Embryonic Stem Cell Market 2013-2023 by Top Key Players, YoY Growth, Trends, Size, Share and Revenue Analysis - Market... - December 24th, 2019
- Researchers Create Functional Mini-Liver by 3D Bioprinting - 3D Printing Progress - December 24th, 2019
- FY 2020 Government Funding Bill Repeals ACA Health-Related Taxes, Extends Expiring Health Provisions, Makes Other Health Policy Updates - Lexology - December 24th, 2019
- Making advanced therapies takes industrializing personalization - STAT - December 23rd, 2019
- Global Allogeneic Stem Cells Market 2020-2024 | Evolving Opportunities with Biosolution Co. Ltd. and Cynata Therapeutics Ltd. | Technavio - Yahoo... - December 23rd, 2019
- Stem Cell Market SWOT Analysis 2019 | Industry Leading Players by Size, Share, Industry Revenue, and Regional Forecast to 2024 - Ankeny Observer - December 23rd, 2019
- BeiGene Announces Acceptance of a Supplemental New Drug Application in China for REVLIMID in Relapsed or Refractory Indolent Lymphoma - BioSpace - December 23rd, 2019
- Stem Cell Research & Therapy | Home page - December 18th, 2019
- Global Allogeneic Stem Cells Market 2020-2024 | Evolving Opportunities with Biosolution Co. Ltd. and Cynata Therapeutics Ltd. | Technavio - Business... - December 18th, 2019
- 3D Cell Culture Market: Hydrogel, Hanging Drop, Bioreactor, Microfluidics, Magnetic Levitation - Global Forecast to 2024 - ResearchAndMarkets.com -... - December 18th, 2019
- Functional "Mini-liver" Created By 3D Bioprinting - Technology Networks - December 18th, 2019
- Scientists hope MND cure is a step closer after stem cell breakthrough discovery - The National - December 18th, 2019
- Stem Cell Banking Market: Adopts Innovation to Stay Competitive Forecast - Market Research Sheets - December 18th, 2019